I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Seegobin, Seth
52
results:
Search for persons
X
Format
Online (52)
Mediatypes
Articles (Online) (24)
OpenAccess-fulltext (28)
Sorted by: Relevance
Sorted by: Year
?
1
Immunogenicity and safety of beta variant COVID-19 vaccine ..:
Costa Clemens, Sue Ann
;
Jepson, Brett
;
Bhorat, Qasim E
...
The Lancet Microbe. , 2024
Link:
https://doi.org/10.1016/..
?
2
Serum AZD7442 (tixagevimab–cilgavimab) concentrations and i..:
Clegg, Lindsay E
;
Stepanov, Oleg
;
Matthews, Sam
...
Clinical & Translational Immunology. 13 (2024) 6 - p. , 2024
Link:
https://doi.org/10.1002/..
?
3
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevi..:
Levin, Myron J.
;
Ustianowski, Andrew
;
De Wit, Stephane
...
Infectious Diseases and Therapy. 13 (2024) 6 - p. 1253-1268 , 2024
Link:
https://doi.org/10.1007/..
?
4
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevim..:
Hobbs, F. D. Richard
;
Montgomery, Hugh
;
Padilla, Francisco
...
Infectious Diseases and Therapy. 13 (2024) 3 - p. 521-533 , 2024
Link:
https://doi.org/10.1007/..
?
5
Immunogenicity and safety of AZD2816, a beta (B.1.351) vari..:
Ramasamy, Maheshi N
;
Kelly, Elizabeth J
;
Seegobin, Seth
...
The Lancet Microbe. 4 (2023) 11 - p. e863-e874 , 2023
Link:
https://doi.org/10.1016/..
?
6
1354. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Preven..:
Levin, Myron J
;
Ustianowski, Andrew
;
De Wit, Stéphane
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
7
529. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Treatme..:
Richard Hobbs, F D
;
Montgomery, Hugh
;
Padilla, Francisco
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
8
1353. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Post-e..:
Levin, Myron J
;
Ustianowski, Andrew
;
Thissen, Jesse
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
9
Safety, Tolerability and Pharmacokinetics of Half-Life Exte..:
Forte-Soto, Pablo
;
Albayaty, Muna
;
Brooks, Dennis
...
The Journal of Infectious Diseases. 227 (2023) 10 - p. 1153-1163 , 2023
Link:
https://doi.org/10.1093/..
?
10
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) ..:
Hobbs, F. D. Richard
;
Montgomery, Hugh
;
Padilla, Francisco
...
Infectious Diseases and Therapy. 12 (2023) 9 - p. 2269-2287 , 2023
Link:
https://doi.org/10.1007/..
?
11
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophyla..:
Levin, Myron J
;
Ustianowski, Andrew
;
Thomas, Steven
...
Clinical Infectious Diseases. 76 (2022) 7 - p. 1247-1256 , 2022
Link:
https://doi.org/10.1093/..
?
12
1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing..:
Richard Hobbs, F D
;
Montgomery, Hugh
;
Padilla, Francisco
...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022
Link:
https://doi.org/10.1093/..
?
13
Efficacy and safety of intramuscular administration of tixa..:
Montgomery, Hugh
;
Hobbs, F D Richard
;
Padilla, Francisco
...
The Lancet Respiratory Medicine. 10 (2022) 10 - p. 985-996 , 2022
Link:
https://doi.org/10.1016/..
?
14
LB5. PROVENT: Phase 3 Study of Efficacy and Safety of AZD74..:
Levin, Myron J
;
Ustianowski, Andrew
;
De Wit, Stéphane
...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S810-S810 , 2021
Link:
https://doi.org/10.1093/..
?
15
Genome-wide association study in frontal fibrosing alopecia..:
Tziotzios, Christos
;
Petridis, Christos
;
Dand, Nick
...
Nature Communications. 10 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1038/..
1-15